Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel neuroprotective agent developed at Takeda

Sep. 15, 1997

Cardiovascular effects of SB-209509 and sumatriptan compared in dogs

Sep. 15, 1997

Amphetamines may provide long-term benefit in patients with ADHD

Sep. 15, 1997

Kyowa Hakko antiparkinsonian enters phase II trials

Sep. 15, 1997

Preclinical studies show broad antiseizure properties of ganaxolone

Sep. 15, 1997

Capases: a new target for neurodegenerative disease therapy

Sep. 12, 1997

Essential tremor gene located by Icelandic genomics company

Sep. 12, 1997

Focus on Alzheimer's disease research in the U.S.

Sep. 12, 1997

Novartis launches Exelon

Sep. 11, 1997

New atypical antipsychotic agent from HMR

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...